This is consistent with previous studies showing baicalin to have anti-inflammatory effects in vitro in a mouse macrophage cell line [46] and in a rat model of hepatotoxicity and a mouse model of non-alcoholic fatty liver disease where it reduced serum TNF-α levels [47, 48]. This evidence concerns the gene TNF and metabolic dysfunction-associated steatotic liver disease.